Jaguar Health (JAGX) Share-based Compensation Growth (1y) (2015 - 2026)
Jaguar Health (JAGX) Share-based Compensation Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
-48.50% |
| Date | Value |
|---|
| Mar 31, 2026 |
-48.50% |
| Dec 31, 2025 |
-68.82% |
| Sep 30, 2025 |
-56.45% |
| Jun 30, 2025 |
-27.15% |
| Mar 31, 2025 |
-48.19% |
| Dec 31, 2024 |
-35.53% |
| Sep 30, 2024 |
-42.27% |
| Jun 30, 2024 |
-26.06% |
| Mar 31, 2024 |
21.04% |
| Dec 31, 2023 |
45.34% |
| Sep 30, 2023 |
-36.15% |
| Jun 30, 2023 |
-38.41% |
| Mar 31, 2023 |
-54.84% |
| Dec 31, 2022 |
-65.24% |
| Sep 30, 2022 |
-27.81% |
| Jun 30, 2022 |
-18.43% |
| Mar 31, 2022 |
67.67% |
| Dec 31, 2021 |
78.44% |
| Sep 30, 2021 |
72.59% |
| Jun 30, 2021 |
37.65% |
